GENE ONLINE|News &
Opinion
Blog

Licensing
Licensing FDA
FDA in Review: What’s Next for Biosimilars, Generic Drugs, and the Orange Book?
2025-01-27
Industry FDA
Drug Promotion, Nonprescription Pathways, and Advanced Manufacturing: FDA’s Key Focus Areas in 2024 and What’s Next for 2025
2025-01-23
Licensing FDA ApprovalAnaphylaxis
The First-Ever Nasal Spray for Anaphylactic Shock Gets FDA Approval
2024-08-12
Deals Acquisitions
Merck Strikes $1.3 Billion Deal to Acquire Curon’s B-Cell Therapy Drug
2024-08-12
Licensing RocheDiabetesEU Approval
Roche Secures CE Mark for AI-Powered Glucose Monitoring Solution, Enhancing Diabetes Care with Predictive Insights
2024-07-11
Partnerships Novo NordiskTargeted Protein Degradation
Neomorph Links Together With Novo Nordisk in a $1.46 Billion Molecular Glue Partnership Deal
2024-02-27
Licensing Astellas PharmaGene Therapy
Astellas Secures Licensing Agreement with 4D Molecular Therapeutics for Gene Therapy Vector Technology
2023-07-12
Partnerships Johnson & JohnsonCAR T-cell Therapy
J&J Puts Up $245 Million for Two Promising Autologous CAR-T Candidates
2023-05-05
Licensing Antibiotic Treatment
GSK Bets $593 Million To License Scynexis’ Oral Antifungal
2023-03-31
Licensing
Vertex and CRISPR Collaborate Again with $330 Million Diabetes Gene Editing Deal
2023-03-28
Licensing Lipid Nanoparticle
Moderna Injects $76 Million To Kickstart Lipid Nanoparticle Delivery Partnership With Generation Bio
2023-03-24
Licensing JAK Inhibitor
Biohaven Licenses TYK2/JAK1 Dual Inhibitor From China’s Highlight In $970 Million Pact
2023-03-23
Licensing Antibody Therapy
OncoC4 Bags $200 Million In CTLA-4 Antibody Pact With BioNTech
2023-03-21
Licensing Epstein-Barr Virus
Merck Strikes $50 Million Deal with ModeX For Rights to EBV Vaccine
2023-03-08
Licensing Allogeneic Cell Therapy
Lineage Books Eterna For Allogeneic Cell Therapies In License Option Deal
2023-02-23
1 2 3 … 8
LATEST
Regeneron Steps In to Rescue 23andMe From Bankruptcy With $256M Acquisition
2025-05-20
Virtual trial shows combo rescue inhaler nearly halves severe asthma attacks
2025-05-20
Lunit Surpasses 1 Million Mammograms in U.S. One Year After Volpara Acquisition
2025-05-19
The Fight Against Hard-to-Treat Cancers : Bold Bets on a Multifaceted Approach
2025-05-19
CRISPR Makes History with First One-of-a-Kind Gene Therapy for Infant
2025-05-19
VintaBio Showcases High-Yield VintaProcess Platform for Gene Therapy Vector Production at ASGCT 2025
2025-05-15
Neurodegenerative and Metabolic Disease Challenges and Solutions at ASGCT 2025
2025-05-15
READ MORE
EVENT
2025-05-26
2025 Antibody Therapeutic & Frontiers in Biomedical Sciences Conference
Taipei, Taiwan
2025-05-30
ASCO Annual Meeting 2025
Chicago, U.S.A
2025-06-11
ISSCR 2025 Annual Meeting
Hong Kong
2025-06-16
US BIO International Convention
Boston, U.S.A.
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2025 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top